CAS: 859209-74-8 - GS-9219
Fórmula:C21H35N8O6P
InChI:InChI=1S/C21H35N8O6P/c1-5-34-19(30)13(3)27-36(32,28-14(4)20(31)35-6-2)12-33-10-9-29-11-23-16-17(24-15-7-8-15)25-21(22)26-18(16)29/h11,13-15H,5-10,12H2,1-4H3,(H2,27,28,32)(H3,22,24,25,26)/t13-,14-/m0/s1
Clave InChI:InChIKey=ANSPEDQTHURSFQ-KBPBESRZSA-N
SMILES:O=C(OCC)C(NP(=O)(NC(C(=O)OCC)C)COCCN1C=NC=2C(=NC(=NC21)N)NC3CC3)C
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Rabacfosadine REF: TM-T16716CAS: 859209-74-8 | 98.75% - 99.43% | 153,00 €~1.573,00 € | Jue 17 Oct 24 |
 | Rabacfosadine REF: 3D-JJB20974CAS: 859209-74-8 | Min. 95% | A consultar | Lun 25 Nov 24 |
Rabacfosadine
CAS:859209-74-8
Rabacfosadine (GS-9219) is a novel prodrug of PMEG, an acyclic nucleotide phosphonate, with antitumor activity …
Fórmula:
C21H35N8O6P
Pureza:
98.75% - 99.43%
Forma y color:
Solid
Peso molecular:
526.53
Ref: TM-T16716
| 1mg | 153,00 € | ||
| 5mg | 364,00 € | ||
| 10mg | 542,00 € | ||
| 25mg | 869,00 € | ||
| 50mg | 1.179,00 € | ||
| 100mg | 1.573,00 € |
Entrega estimada en Estados Unidos, el Jueves 17 de Octubre de 2024
Rabacfosadine
CAS:859209-74-8
Rabacfosadine is a novel antiviral drug that has been shown to be effective in the …
Fórmula:
C21H35N8O6P
Pureza:
Min. 95%
Peso molecular:
526.5 g/mol
Ref: 3D-JJB20974
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Lunes 25 de Noviembre de 2024
